Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




FDA Warns Glaxo on Cancer Drug Promotions
Link ID 1187
Title FDA Warns Glaxo on Cancer Drug Promotions
Url http://www.medscape.com/viewarticle/566544?src=rss
Description GlaxoSmithKline PLC sent misleading letters to health professionals touting its breast cancer drug Tykerb, U.S. health officials said in a letter released on Monday. Reuters Health Information
Category Articles > Business of Medicine
Keywords
Date Nov 30, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. International Bodies Call for G8 Action on Health
  Leaders of the Group of Eight (G8) rich nations meeting in Japan next month must tackle health scourges in developing countries to boost global prosperity and security, eight international organisations said on Monday. Reuters Health Information
Category:   Articles > Business of Medicine


2. World Health Organization Issues Safety Checklist for Surgical Teams
  To improve surgical safety and reduce surgical errors worldwide, the World Health Organization has released a new safety checklist for surgical teams to use in operating rooms. Medscape Medical News
Category:   Articles > Business of Medicine


3. US Children Have Significant Limits on the Quality of Care Received
  A study published in the October 11, 2007 issue of the NEJM examines the quality of care delivered to children and adolescents in the ambulatory setting.
Medscape Pediatrics
Category:   Articles > Business of Medicine


4. Palliative Sedation Increases as Euthanasia Declines in Netherlands
  In the Netherlands, where euthanasia is legal but regulated by law, the use of continuous deep sedation for patients near death increased between 2001 and 2005, while the use of euthanasia declined. Reuters Health Information
Category:   Articles > Business of Medicine


5. Glaxo Gets Formal EU Okay for Breast Cancer Drug
  GlaxoSmithKline Plc has received formal European marketing authorisation for its new breast cancer pill Tyverb, the drugmaker said on Thursday. Reuters Health Information
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS